1. Home
  2. BMEA vs CURI Comparison

BMEA vs CURI Comparison

Compare BMEA & CURI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biomea Fusion Inc.

BMEA

Biomea Fusion Inc.

HOLD

Current Price

$1.40

Market Cap

138.1M

Sector

Health Care

ML Signal

HOLD

Logo CuriosityStream Inc.

CURI

CuriosityStream Inc.

HOLD

Current Price

$3.29

Market Cap

149.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMEA
CURI
Founded
2017
N/A
Country
United States
United States
Employees
N/A
42
Industry
Biotechnology: Pharmaceutical Preparations
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
138.1M
149.4M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BMEA
CURI
Price
$1.40
$3.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
3
Target Price
$9.83
$5.83
AVG Volume (30 Days)
1.2M
555.0K
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
10.36%
EPS Growth
69.19
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$14.91
Revenue Next Year
N/A
$12.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.87
$2.30
52 Week High
$3.07
$7.15

Technical Indicators

Market Signals
Indicator
BMEA
CURI
Relative Strength Index (RSI) 45.33 59.22
Support Level $1.23 $3.00
Resistance Level $1.45 $3.56
Average True Range (ATR) 0.10 0.18
MACD 0.00 0.04
Stochastic Oscillator 47.57 98.94

Price Performance

Historical Comparison
BMEA
CURI

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It operate as an organization centered on two of its core drug candidate development programs: (i) icovamenib, its clinical program's drug candidate, currently being developed as an orally bioavailable, and selective, covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity, and (ii) BMF-650, its investigational, next-generation oral glucagon-like peptide-1 GLP-1 receptor agonist in development for the treatment of obesity.

About CURI CuriosityStream Inc.

CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. The firm's products and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, and Others. The majority of the revenue comes from the direct business and Content licensing. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: